Cambridge, MA, United States of America

David Fabrizio

This inventor holds 7 USPTO granted patents and 10 published patent applications and 3 EPO patents. Top assignees: Foundation Medicine, Inc., Genentech, Inc., Vanderbilt University. Active years: 2022-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: David Fabrizio. Retrieved from https://idiyas.com/inventor/david-fabrizio-12kbdshj

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 7 

% Patents Active = 85.7

 

Average Co-Inventor Count = 8.3

ph-index = 2

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2022-2026

Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: David Fabrizio: Innovating Cancer Treatment

Introduction

David Fabrizio, an influential inventor based in Cambridge, MA, has made significant contributions to the field of oncology through his innovative methods and compositions for treating cancer. With a portfolio that boasts four patents, his work focuses on developing therapeutic and diagnostic approaches that enhance patient care and treatment outcomes.

Latest Patents

Fabrizio's most recent patents revolve around groundbreaking methods for treating cancer, particularly melanomas and other forms. His inventions disclose unique therapeutic and diagnostic methods aimed at helping clinicians determine how individual patients may respond to specific treatments, including immune checkpoint inhibitors like PD-L1 axis binding antagonists. By integrating factors such as blood tumor mutational burden (bTMB) scores and maximum somatic allele frequency (MSAF) into the treatment process, his inventions enhance prognostic capabilities and enable tailored therapies for cancer patients.

Career Highlights

Throughout his career, David Fabrizio has built a robust professional background by working with some leading companies in the biotechnology sector. Notably, he has been associated with Foundation Medicine, Inc. and Genentech, Inc., where he applied his innovative mind to push the boundaries of cancer treatment and understandings further.

Collaborations

In his journey as an inventor, Fabrizio has collaborated with talented individuals in the field, including Garrett Michael Frampton and Philip James Stephens. These partnerships have undoubtedly contributed to refining his ideas and expanding his research capabilities, resulting in impactful innovations that benefit many.

Conclusion

David Fabrizio stands as a significant figure in advancing cancer treatment methodologies. His dedication to innovation and collaboration highlights the importance of continued research and development in the fight against cancer. With his ongoing contributions, we can anticipate further breakthroughs that will transform patient care and treatment efficacy in oncology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…